Octacosanol Attenuates Inflammation in Both ... - ACS Publications

Subscriber access provided by University of Newcastle, Australia

Article

Octacosanol attenuates inflammation in both RAW264.7 macrophages and a mouse model of colitis Tianyi Guo, Qinlu Lin, Xinhua Li, Ying Nie, Long Wang, Limin Shi, Wei Xu, Tao Hu, Ting Guo, and Feijun Luo J. Agric. Food Chem., Just Accepted Manuscript • DOI: 10.1021/acs.jafc.6b05465 • Publication Date (Web): 26 Jan 2017 Downloaded from http://pubs.acs.org on January 28, 2017

Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a free service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are accessible to all readers and citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.

Journal of Agricultural and Food Chemistry is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.

Page 1 of 43

Journal of Agricultural and Food Chemistry

1 2 3

Octacosanol Attenuates Inflammation in Both RAW264.7

4

Macrophages and a Mouse Model of Colitis

5

Tianyi Guo, †,§ Qinlu Lin, †,§ Xinhua Li, ‡ Ying Nie, † Long Wang, † Limin Shi, † Wei Xu, † Tao Hu, † Ting Guo, † and Feijun Luo†,#

6 7 8 9

†

Laboratory of Molecular Nutrition, National Engineering Laboratory for Rice and

10

Byproducts, College of Food Science and Engineering, Central South University of

11

Forestry and Technology, Changsha, Hunan 41004, China

12

‡

13

Changsha, Hunan 410008, China

Department of Gastroenterology, Xiangya Hospital, Central South University,

14 15 §

Contributed equally to this work.

17

#

Corresponding author, Dr. Feijun Luo, Laboratory of Molecular Nutrition, College

18

of Food Science and Technology, Central South University of Forestry and

19

Technology, 498, Shaoshan Road, Changsha, 410004, China.

20

Tel: +86-731-85623240, Feijun Luo Email: [email protected];

21

[email protected].

16

22 23

1

ACS Paragon Plus Environment


24

ABSTRACT: Octacosanol has multiple biological functions. In this study, the

25

anti-inflammatory effect and molecular mechanism of octacosanol were evaluated by

26

using dextran sulfate sodium (DSS)-induced ulcerative colitis model in mice and

27

lipopolysaccharide (LPS)-stimulated mouse macrophage RAW264.7 cells. The colitis

28

mouse model was induced by 3.0% DSS in 8-week ICR mice and octacosanol oral

29

administered with 100mg/kg/day. The results showed that octacosanol significantly

30

improved the health status of mice and reduced DSS-induced pathological damage in

31

the colonic tissues. Octacosanol obviously inhibited the mRNA and protein expression

32

levels of pro-inflammatory factors of colonic tissues. In vitro study, octacosanol

33

administration significantly reduced the expression of mRNA or protein of

34

pro-inflammatory cytokines and the phosphorylation of c-Jun N-terminal kinase and

35

p38, and it also partly prevented LPS-induced the translocations of NF-κB and AP-1.

36

Octacosanol has anti-inflammatory effect and its molecular mechanism may be

37

involved in down-regulating the expression of inflammatory factors and blocking of

38

MAPK/ NF-κB/AP-1 signaling pathway.

39

KEYWORDS: octacosanol, colitis, inflammation factor, MAPK, NF-κB, AP-1

40 41 42 43 44 45

2


Page 2 of 43

Page 3 of 43


46

INTRODUCTION

47

With the improvement of living standards and the diversification of diets, the

48

incidence of digestive disease including inflammatory bowel disease (IBD) has

49

increased considerably over the past decades.1 The ulcerative colitis disease (UC) is

50

induced by multi factors and is one of the common non-specific inflammatory bowel

51

diseases. UC has a long disease course and is a great risk factor leading to colorectal

52

cancer. 2 Blood stool and pus, diarrhea and abdominal pain are the main symptoms of

53

UC patients. Its ulcer lesions are mainly located in the mucosal layer of the colon,

54

involving the rectum, distal colon even extended to the proximal or entire colon. 3 UC

55

was listed as one of the modern refractory diseases by the WHO.4,5 So far, the etiology

56

of UC has not yet completely been understood. Anti-inflammation and regulating the

57

immune response are the main measures for UC treatment, including medication of

58

5-ASA drugs, corticosteroids and immunosuppressors, cell therapy or surgical

59

treatments. However, these therapies have high risks of adverse effects (such as sleep

60

and mood disturbances, dyspepsia, and glucose intolerance), high recurrence rate and

61

poor tolerance, they are not suitable as long term therapies, and new measures for

62

adjunct therapies are needed. 6,7

63

Octacosanol, the main component of policosanol, is a kind of high-level saturated

64

fatty alcohol which exists in natural plants such as rice, sugar cane in the form of wax

65

ester.8 Many studies have reported that octacosanol plays a positive role in many

66

physiological functions, including reducing blood sugar and lipid,9,10 resisting fatigue,

67

11,12

regulating cardiovascular function13,14 and so on.15 In addition, toxicity

3



Page 4 of 43

68

experiments have demonstrated that it has wide safety margin when administered

69

chronically in rats,16 which is safer compared to the same dose of salt. Benefited from

70

its high security, octacosanol could be used as a kind of drug or food additives without

71

any

72

anti-inflammatory effects. For example, it can increase neutrophil influx of

73

carcinogen-induced mouse and inhibit the expression of tumor necrosis factor-α

74

(TNF-α).17 A long chain fatty alcohol mixture extracted from evening primrose seed

75

oil (octacosanol content is 7.64%) reduces nitric oxide (NO) content and release of

76

interleukin-1β (IL-1β) in lipopolysaccharide (LPS)-stimulated RAW264.7 cells.18 It

77

suggests that the octacosanol may have a potential anti-inflammatory effect.

side

effects.

Some

evidences

suggest

that

octacosanol

may

have

78

To simulate the clinical symptoms of UC, a classic model of the colitis induced

79

by dextran sulfate sodium (DSS) was used in this study. The model has the advantages

80

of low cost, simple preparation, good repeatability and easy operation. Experimental

81

animals induced by DSS exhibits the characteristics resembling human UC, for

82

instance severe diarrhea, weight loss, ulceration and leukocyte infiltration.19,20 As a

83

physiological response to infection or injury, the macrophage plays a critical role in

84

inflammation.21,22 It produces different cytokines or releasing of lysosomal enzymes,

85

macrophages mediate directly or indirectly the process of inflammatory reaction.23

86

LPS has widely used to induce the inflammatory response of macrophages for the

87

study of anti-inflammatory mechanism. LPS could stimulate a series of expression of

88

cytokines proteins caused by activating cell signaling pathway, including

89

mitogen-activated protein kinases (MAPK) and nuclear factor kappa-B (NF-κB),

4


Page 5 of 43


90

which are the major kinase families associated with the inflammation process. 24,25

91

So far, there is no report provides direct evidences about octacosanol inhibiting

92

inflammation in classical inflammatory models. In this study, we examined the

93

anti-inflammatory effects of octacosanol by using both LPS-stimulated RAW264.7

94

cell and DSS-induced mouse model. The study also evaluated the effects of

95

octacosanol on NF-κB and MAPK signaling pathways and revealed the possible

96

anti-inflammation mechanism of octacosanol.

97 98

MATERIALS AND METHODS

99

Materials and Reagents. DSS (purity: 100% MP Biomedicals, Illkirch, France.

100

Molecular weight 36-50 kDa, Lot number M2066); Octacosanol (flake-like white

101

powder, extracted from rice bran, purity 99%, Sigma Aldrich Co., St. Louis, Mo.,

102

USA); Stock solutions of octacosanol were dissolved in ethanol and octacosanol

103

solutions were performed by ultrasonic concussion for 5 min. NO assay kit, MDA

104

assay kit and MPO assay kit were purchased from Nanjing Jiancheng, Nanjing, China.

105

LPS from Escherichia coli O127:B8 was purchased from Sigma Aldrich Co. (St.

106

Louis, Mo., USA). RPMI 1640 and fetal bovine serum were purchased from

107

Gibco-BRL (Gibco-BRL, Carlsbad, CA, USA). Nuclear and Cytoplasmic Protein

108

Extraction Kit (P0028) and Enhanced BCA protein kit (P0009) were purchased from

109

Beyotime Biotechnology (Shanghai, China). Polyclonal antibody TNF-α (Cat#11948),

110

IL-1β (Cat#12507), inducible nitric oxide synthase (iNOS) (Cat#13120), interleukin-6

111

(IL-6) (Cat#12912), β-Actin (Cat#12620), phospho-MAPK Sampler Kit (Cat#9910),

5



112

MAPK Family Antibody Sampler Kit (Cat#9926), SP600125, U0126 and SB203580

113

were purchased from Cell Signaling Technology Company (Beverly, MA, USA).

114

Anti-Mouse IgG HRP Conjugate (W4021) and anti-rabbit IgG HRP Conjugate

115

(V7951) were purchased from Promega Corporation (Madison, Wl, USA). All other

116

reagents of this study were the analytical grade.

117

Experimental Animals. Total 60 8-week-old，weight between 30-35 g, half of

118

each sex ICR mice were purchased from Hunan SJA Laboratory Animal Co., Ltd

119

(SLAC, Changsha, Hunan, China) and were fed with standard laboratory chow in the

120

animal room with 12h dark/light cycles and constant temperature of 23±2℃. Before

121

treatment, animals were fed with a laboratory diet (SLAC, Changsha, Hunan, China)

122

and water ad libitum. After one week of adaptation period, these mice were randomly

123

divided into 3 groups (20 mice per group). Mice in control group were given drinking

124

water ad libitum for 13 days. The DSS group and the DSS+Oct group were given

125

drinking water with 3% (w/v) DSS only from the third day to the end of the

126

experiment (DSS treatment period were 11 days). And the mice of octacosanol group

127

were additionally administrated octacosanol suspension with water (100mg/kg/day)

128

from the third day of DSS treating to the end of 13 days experimental period. The use

129

of the animals and experimental protocols were approved by the Guidelines for the

130

Care and Use of Experimental Animals, the Hunan Normal University School of

131

Medicine (SYXK(Xiang) 2014-0006), and the study was approved by the office of

132

Animal Experiment Ethnics, Central South University of Forestry and Technology.

133

Evaluation of Disease Activity Index (DAI). During the experimental period,

6


Page 6 of 43

Page 7 of 43


134

the body weight, food and water intake, mental state, stool consistency and gross

135

bleeding were recorded at the same time every day. DAI score was determined by

136

combining scores of body weight loss, stool consistency and gross bleeding26 and it

137

was described in Table 1. Determination of fecal occult blood: small amount of feces

138

was smeared evenly on the glass slide with sterilized cotton swab. After adding a few

139

drops of orthotolidine (o-TD), add a few more drops of 3% H2O2. Judgment standard

140

of fecal occult blood: the fecal color has no significant change in 2 minute should be

141

determined as negative; the color changes blue and becomes gradually (blue brown)in

142

10s should be determined as weak positive; the color changes from light blue brown

143

to deep (blue brown) should be determined as positive; the color shows the blue

144

brown immediately should be strong positive. At the end of the experiment, body

145

weight and spleen weight were measured immediately，and the colon tissues of

146

sacrificed mice were separated from the proximal rectum. The colon length between

147

the ileo-cecal junction and the proximal rectum was subsequently measured.

148

MPO and MDA Assay. The middle segments of the colon tissues were

149

intercepted and myeloperoxidase (MPO) and malonic dialdehyde (MDA) contents

150

were detected. The tissues (50-100mg) were washed and homogenized in pre-cold

151

phosphate buffered saline (homogenate concentration is 10% w/v). According to the

152

protocols specification, MPO and MDA assays were carried strictly. The MPO

153

activity was expressed in terms of units/g tissue (IU/g), and the content of MDA was

154

in terms of nmol MDA/mg tissue protein (nmol/mg).

155

NO Assay. NO is instable in vivo and easy to be converted to nitrite (NO2-) or

7



156

nitrate (NO3-), so the NO production was indirectly calculated by measuring the nitrite

157

and nitrate levels. Centrifuged the mice blood at 4000 rpm for 20 min at 4°C, and the

158

supernatants were analyzed the content of nitrite and nitrate content according to the

159

protocol of NO assay kits.

160

Histopathology Analysis. The middle segments of the colon tissues were

161

intercepted and fixed in 10% (100 g/L) formalin solution for 24h, then dehydrated

162

with increasing concentrations of ethanol, transparented the sections using xylene and

163

embedded in molten paraffin. Sections of colon tissue were cut into 5µm slices on a

164

microtome and then put on clean glass slides and dried at 37°C overnight. Tissues

165

were dewaxed by xylene and dehydrated by different concentrations of ethanol. These

166

sections were stained with hematoxylin and eosin (H&E), and the morphometry of

167

intestinal epithelia cell, loss of crypt glands and density of neutrophil and lymphocyte

168

infiltration would be observed under the microscope.

169

Cell culture. The mouse monocyte-macrophage cell line RAW264.7 was

170

purchased from BioHermes Co. (Wuxi, China) and the cell line are originated from

171

ATCC (American Type Culture Collection, USA). RAW264.7 cells were incubated in

172

Dulbecco’s modified Eagle’s medium (DMEM) containing 10% heat inactivated fetal

173

bovine serum (FBS), 100 U/ml streptomycin and 100 U/ml penicillin at 37℃ and 5%

174

CO2. The medium was replenished three times a week and cells were subcultured

175

using 0.25% trypsin timely.

176

Total RNA extraction and quantitative RT-PCR. Tissues (100mg) of the

177

middle segment of the colon were intercepted and were ground in liquid nitrogen

8


Page 8 of 43

Page 9 of 43


178

pre-cooling mortar. Raw264.7 cells were seeded at 1×106 cells per mL in 6-wells

179

plates and incubated overnight. Cells were treated with octacosanol (0, 10, 30 and

180

100µg/mL) for 2 hours followed by adding LPS (1µg/mL) for 6 hours. Total RNA

181

from cells or colon tissues was extracted by using Transzol-Up reagent according to

182

the manufacturer's instructions. The quality, purity and concentration of RNA sample

183

were analyzed using Nanodrop ultramicro spectrophotometer instrument. The

184

resulting RNA (2µg) was used as a template for reverse-transcribing to first-strand

185

cDNA synthesis by using High-Capacity cDNA Reverse Transcription Kits in a total

186

volume of 20 µL. Real-time quantitative polymerase chain reaction (RT-qPCR) was

187

performed by the CFX96 Real Time PCR system (Applied Bio systems) using

188

SYBR® Select Master Mix (Applied Bio systems) referring to the protocol. The

189

sequences of primers (pro-inflammatory cytokines TNF-α, IL-1β, iNOS, IL-6 and

190

β-actin, control for qPCR) used for RT-qPCR analysis. The amplification conditions:

191

94℃，initial denaturation for 3 min；94℃，denaturation for 30 s；60℃，annealing for

192

40 s；72℃，extension for 1 min, 40 cycles. Relative expression levels of the target

193

genes were calculated based on 2-△△Ct（RQ）method. The PCR primers were used as

194

following: IL-1β forward: 5’ GAG CAC CTT CTT TTC CTT CAT CTT 3’, reverse: 5’

195

TCA CAC ACC AGC AGG TTA TCA TC 3’; IL-6 forward: 5’ ATG GAT GCT ACC

196

AAA CTG GAT 3’, reverse: 5’ TGA AGG ACT CTG GCT TTG TCT 3’; iNOS

197

forward: 5’CAG CTG GGC TGT ACA AAC CTT-3’; reverse: 5’CAT TGG AAG

198

TGA AGC GTT TCG3’；TNF-α forward: 5’ CAA AAT TCG AGT GAC AAG CCT G

199

3’, reverse: 5’ GAG ATC CAT GCC GTT GGC 3’; β-actin forward: 5’ ATC ATG TTT

9



200

GAG ACC TTC AAC ACC3’, reverse: 5’ TAG AGC AAC ATA GCA CAG CTT CTC

201

TT 3’.

202

Preparation of Total/Nuclear Lysates. Raw264.7 cells were seeded at a

203

concentration of 1×106 cells/mL in 10cm petri dish and incubated overnight. Cells

204

were treated with octacosanol (0, 10, 30 and 100µg/mL) for 2 hours followed by

205

exposure to LPS (1µg/mL) for 1 hours. Before the extracting of protein, stimulated

206

RAW264.7 cells were harvested and washed twice with ice-cold PBS. Tissues (100mg)

207

removed from colon were ground in liquid nitrogen pre-cooling mortar. Total protein

208

from cells or colon tissues was extracted with RIPA buffer (0.1% deoxycholate, 1%

209

Triton X-100, 0.5% SDS, 2mM PMSF, 2mM EDTA and 2mM orthovanadate)

210

supplemented with a cocktail of protease and phosphatase inhibitors. The cell nuclear

211

and cytoplasmic proteins were extracted using cytoplasm/nucleus protein extraction

212

reagents referring to manufacturer's instructions. The concentration of protein samples

213

were determined using bicinchoninic acid (BCA) protein assay kit with Nanodrop

214

ultramicro spectrophotometer instrument.

215

Western Blot Analysis. The prepared protein samples were mixed in equal

216

amounts (10-20µg) with 2×SDS loading buffer (125mM Tris-HCl, pH 6.8, 10%

217

2-mercaptoethanol, 4% SDS, 20% glycerol, and 0.3% bromophenol blue), boiled for 5

218

min at 95℃. Then the mixture was loaded to electrophoresis on 10%-15% SDS-PAGE

219

gel followed by transferring onto a polyvinylidene difluoride (PVDF) membrane. The

220

membranes combined with protein of target gene were blocked with 5% bovine serum

221

albumin (BSA) in Tris-buffered saline with Tween20 (TBST) for about 1h at room

10


Page 10 of 43

Page 11 of 43


222

temperature. After being blocked, the membrane was incubated with a 1:1000 dilution

223

of primary antibody in 5% BSA with TBST at 4℃ for overnight. Then the membrane

224

was washed three times for 30min with TBST at room temperature and then incubated

225

with a 1:5000-10000 dilution of anti-mouse/ anti-rabbit IgG secondary antibody for

226

1h at 4℃. After washed three times for 30min with TBST, the immunoreactive

227

proteins were detected using the ECL Plus™ Western blot detection system (Pierce,

228

Rockford, USA) and was imaged in the Gel Imaging System (ChemiDoc™ XRS+,

229

BIO-RAD). The relative expression quantity of the target protein compared to the

230

control protein was determined through calculating the integral light density value of

231

each band using the imaging system.

232

Luciferase Reporter Activity Assay. RAW264.7 cells were seeded at a density

233

of 5×105/mL in 24-well plates for overnight incubation. After 24h incubation, the

234

culture medium was removed and replaced with fresh medium without serum,

235

antibiotics. After achieving 80% confluence of cells, culture medium was replaced

236

with fresh serum free medium again at 300 µL/well containing transfection mixture

237

(2µL of pNF-κB/AP-1-luc in 2µL of lipofectamine 2000 reagents) and cells were

238

transferred for 4h. Then the medium mixed with transfection mixture was removed

239

and cells were cultivated in complete medium for 5h. Cells were pre-treated with

240

octacosanol (0, 10, 30 and 100 µg/mL) for 2 hours before stimulation with LPS (1

241

µg/mL). 12 hours after stimulation, the cell were then obtained with 1× reporter lysis

242

buffer, luciferase activity from cell lysates was determined using the luciferase assay

243

system and reporter lysis buffer from Promega. Results of luciferase expression were

11



244

expressed as a relative light units (RLU)/mg protein.

245

Statistical Analysis. Each experiment repeated three times, and the data were

246

analyzed by SPSS 17.0 software (SPSS, Chicago, USA). Results are expressed as the

247

mean±SD and were analyzed by means of one-way ANOVA test analysis followed by

248

Tukey’s test when comparisons proceed among groups. Percentage (ratio)

249

comparisons were used Chi-square test. The value of p less than 0.05 was considered

250

statistically significant.

251 252

RESULTS

253

Octacosanol ameliorates inflammatory symptoms of DSS-induced colitis in

254

mice. In order to investigate the effect of octacosanol on colitis, DSS-induced ICR

255

mice inflammation model was established in the experiments. During the

256

experimental course, phenotypic changes of mice were observed and recorded. After

257

DSS administration, mice show body weight loss, reduced food intake, diarrhea,

258

reduced movements and even hematochezia. DSS-induced mice gavaged with

259

octacosanol (100mg/kg/day) significantly mitigate those symptoms of colitis. DSS

260

treatment resulted in a visible hematochezia at day 7, loss of body weight from

261

35.67±2.13g to 34.05±1.44g. The body weight loss of protection group (DSS+Oct)

262

mice were improved at end of the experiment (Fig. 1A). Contrasted with control

263

group, the score of DAI increased significantly after DSS intake, however, markedly

264

attenuated in octacosanol-treated group. The scores of the two groups were

265

11.05±0.94 and 8.15±1.03 (p

Octacosanol Attenuates Inflammation in Both ... - ACS Publications

Recommend Documents